Sanders Capital
PFE icon

Sanders Capital’s Pfizer PFE Stock Holding History

Sanders Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-12,249,376
Closed -$723M – 45
2021
Q4 		$723M Sell
12,249,376
-6,534,246
-35% -$324M 1.48% 21
2021
Q3 		$808M Sell
18,783,622
-14,691,363
-44% -$651M 1.83% 19
2021
Q2 		$1.31B Buy
33,474,985
+1,272,869
+4% +$49.5M 2.97% 15
2021
Q1 		$1.17B Buy
32,202,116
+254,300
+0.8% +$9.03M 2.81% 16
2020
Q4 		$1.18B Buy
31,947,816
+1,491,455
+5% +$54.7M 3.1% 13
2020
Q3 		$1.06B Buy
30,456,361
+647,121
+2% +$22.7M 3.64% 10
2020
Q2 		$925M Buy
29,809,240
+1,421,859
+5% +$48.3M 3.46% 10
2020
Q1 		$879M Buy
28,387,381
+460,475
+2% +$15.7M 4.12% 9
2019
Q4 		$1.04B Buy
27,926,906
+3,070,825
+12% +$109M 3.67% 9
2019
Q3 		$847M Buy
24,856,081
+5,094,551
+26% +$185M 3.8% 8
2019
Q2 		$812M Buy
19,761,530
+639,461
+3% +$25.4M 3.73% 10
2019
Q1 		$771M Buy
19,122,069
+893,265
+5% +$35.8M 3.7% 8
2018
Q4 		$755M Sell
18,228,804
-1,142,009
-6% -$47.4M 4.2% 5
2018
Q3 		$810M Sell
19,370,813
-1,802,442
-9% -$69.4M 4.08% 8
2018
Q2 		$729M Buy
21,173,255
+22,977
+0.1% +$785K 3.91% 8
2018
Q1 		$712M Sell
21,150,278
-31,725
-0.1% -$1.09M 3.95% 8
2017
Q4 		$728M Buy
21,182,003
+2,717,317
+15% +$92.7M 3.96% 10
2017
Q3 		$625M Buy
18,464,686
+617,223
+3% +$19.8M 3.77% 10
2017
Q2 		$569M Buy
17,847,463
+1,732,814
+11% +$54.6M 3.66% 13
2017
Q1 		$538M Buy
16,114,649
+300,706
+2% +$9.48M 3.57% 13
2016
Q4 		$487M Buy
15,813,943
+991,295
+7% +$30.3M 3.47% 14
2016
Q3 		$476M Sell
14,822,648
-213,962
-1% -$7.15M 3.76% 12
2016
Q2 		$502M Buy
15,036,610
+15,625
+0.1% +$499K 4.17% 10
2016
Q1 		$422M Buy
15,020,985
+4,198,829
+39% +$120M 3.65% 11
2015
Q4 		$331M Buy
+10,822,156
New +$340M 3.04% 14

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Sanders Capital's PFE Position: Q1 2022 in Review

Sanders Capital sold out of Pfizer (PFE) in Q1 2022, closing a stake of 12,249,376 shares — an estimated $723M sold.

Sanders Capital first reported a position in PFE in Q4 2015 and held it in 25 quarters. The position peaked at $1.31B in Q2 2021. 3,195 funds tracked by Wall St. Rank hold PFE as of Q1 2022.

  • Sanders Capital reported no remaining Pfizer position as of Q1 2022 after selling out during the quarter.
  • Sanders Capital sold 12,249,376 Pfizer shares in Q1 2022, an estimated $723M.
  • Sanders Capital first reported a position in Pfizer in Q4 2015 and held it in 25 quarters.
  • Sanders Capital's Pfizer position peaked at $1.31B in Q2 2021.
  • 3,195 funds tracked by Wall St. Rank held Pfizer as of Q1 2022.

Based on Sanders Capital's 13F filing for Q1 2022, filed 20 May 2022.